BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 2677354)

  • 21. [Cytologic diagnosis of cervico-vaginal infections with herpesvirus hominis type II and human papilloma virus].
    Zamfirova K; Karag'ozov I
    Akush Ginekol (Sofiia); 1984; 23(4):344-8. PubMed ID: 6091487
    [No Abstract]   [Full Text] [Related]  

  • 22. Managing abnormal Pap smears: comments on two articles.
    Buck HW
    J Am Coll Health; 1989 Sep; 38(2):101-2. PubMed ID: 2778225
    [No Abstract]   [Full Text] [Related]  

  • 23. [Vaginal and endocervical smears: when and how to do?].
    Quentin R; Pierre F; Leblond MH; Lecointe V
    J Gynecol Obstet Biol Reprod (Paris); 1997; 26(3 Suppl):29-37. PubMed ID: 9471461
    [No Abstract]   [Full Text] [Related]  

  • 24. Recent developments in the cytologic diagnosis of vaginal, endometrial and ovarian cancer.
    Gondos B
    Ann Clin Lab Sci; 1974; 4(6):420-7. PubMed ID: 4429340
    [No Abstract]   [Full Text] [Related]  

  • 25. [An operative model: verification of the quality of the screening Pap test ].
    Montanari GR; Arnaud S; Berardengo E; Campione D; Cozzani C; Parisio F; Viberti L; Ghiringhello B
    Pathologica; 2001 Oct; 93(5):609-10. PubMed ID: 11725370
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cyto-histological and serological correlation in 58 cases of uterine cervical lesions of suspected viral origin].
    Garsia S; Remotti G; Rizzi G; Mazzola G; Masserini M; Lusco G
    Ann Ostet Ginecol Med Perinat; 1979; 100(6):379-83. PubMed ID: 400081
    [No Abstract]   [Full Text] [Related]  

  • 27. Bethesda 2001.
    Smith JH
    Cytopathology; 2002 Feb; 13(1):4-10. PubMed ID: 11985563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The gynecologist's perspective of liability and quality issues with the Papanicolaou smear.
    Greer BE
    Arch Pathol Lab Med; 1997 Mar; 121(3):246-9. PubMed ID: 9111109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Differential diagnostic possibilities based on algorithms from histological study in cervical and vaginal diseases].
    Khmel'nitskiĭ OK; Belianin VL
    Arkh Patol; 1981; 43(11):81-5. PubMed ID: 7316836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving consistency in cervical cytology reporting.
    Mitchell H
    J Natl Cancer Inst; 1993 Oct; 85(19):1592-6. PubMed ID: 8411232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Colpocytohistological correlations of lesions of the uterine portio extending to the fornix vaginae].
    Volante E; Devalle G; Lerro R
    Minerva Ginecol; 1981 Apr; 33(4):337-40. PubMed ID: 7243076
    [No Abstract]   [Full Text] [Related]  

  • 32. Follow-up of the minimally abnormal Pap smear.
    Everett WD
    Am Fam Physician; 1997 Jul; 56(1):56-7. PubMed ID: 9225667
    [No Abstract]   [Full Text] [Related]  

  • 33. The Bethesda system and Pap smear screening.
    Miller K
    Am Fam Physician; 1995 Feb; 51(2):331-2. PubMed ID: 7840027
    [No Abstract]   [Full Text] [Related]  

  • 34. The Bethesda System for reporting cervical/vaginal cytologic diagnoses. Report of the 1991 Bethesda Workshop.
    Am J Surg Pathol; 1992 Sep; 16(9):914-6. PubMed ID: 1415910
    [No Abstract]   [Full Text] [Related]  

  • 35. [Guidelines for the evaluation of internal quality control of smears for screening of uterine cancer in France in the structures of Pathologic Anatomy and Cytology. French Association for Quality Assurance in Pathologic Anatomy and Cytology (AFAQAP)--Commission for cervical smears].
    Albuisson F; Anger E; Baron V; Cartier I; Dorne H; Dubois-Gordeff A; Hassoun J; Jouannelle A; Labbé S; Locquet D; Marsan C; Martin E; Michiels-Marzias D; Molinié V; Mottot C; Mueller B; Vacher-Lavenu MC; Vincent S; Vuong PN
    Ann Pathol; 1998 Jul; 18(3):221-6. PubMed ID: 9750045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Bethesda system for cervical/vaginal cytologic diagnoses.
    Herbst AL
    Clin Obstet Gynecol; 1992 Mar; 35(1):22-7. PubMed ID: 1544245
    [No Abstract]   [Full Text] [Related]  

  • 37. Strategies for reducing Papanicolaou smear screening errors: principles derived from data and experience with quality control.
    Krieger PA
    Arch Pathol Lab Med; 1997 Mar; 121(3):277-81. PubMed ID: 9111118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Bethesda System for reporting cervical/vaginal cytologic diagnoses: report of the 1991 Bethesda workshop. The Bethesda System Editorial Committee.
    Luff RD
    Hum Pathol; 1992 Jul; 23(7):719-21. PubMed ID: 1612572
    [No Abstract]   [Full Text] [Related]  

  • 39. Formal proposal to combine the Papanicolaou Numerical System with Bethesda terminology for reporting cervical/vaginal cytologic diagnoses.
    Frankel K
    Diagn Cytopathol; 1994; 10(4):395-6. PubMed ID: 7924818
    [No Abstract]   [Full Text] [Related]  

  • 40. [Phase contrast microscopic study of vaginal exfoliative cytology. Technic and indications].
    Bourg R
    Brux Med; 1972 Mar; 52(3):189-98. PubMed ID: 4553945
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.